MedTrace Logo

Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?

NCT01997762 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2014-05-12

No results posted yet for this study

Summary

The purpose of this study is to determine if resveratrol supplementation preserves beta cell function and insulin sensitivity in post-partum women following a first diagnosis of gestational diabetes. We hypothesize that daily supplementation with resveratrol will preserve beta cell function and insulin sensitivity.

Conditions

  • Gestational Diabetes

Interventions

DIETARY_SUPPLEMENT

Resveratrol

gel-coated capsules to be taken twice a day; one with breakfast and dinner

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Manitoba Institute of Child Health

    collaborator INDUSTRY

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Shayne P Taback, MD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-12-31
Completion
2016-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01997762 on ClinicalTrials.gov